Geodon



Indications and Reactions:

Role Indications Reactions
Primary
Bipolar Disorder 28.4%
Depression 11.8%
Schizophrenia 10.7%
Anxiety 5.7%
Psychotic Disorder 5.0%
Schizoaffective Disorder 4.7%
Bipolar I Disorder 4.4%
Ill-defined Disorder 4.1%
Hypertension 3.5%
Sleep Disorder 2.8%
Affective Disorder 2.5%
Drug Use For Unknown Indication 2.5%
Major Depression 2.1%
Insomnia 2.0%
Mania 1.9%
Diabetes Mellitus 1.6%
Obsessive-compulsive Disorder 1.6%
Agitation 1.6%
Blood Cholesterol Increased 1.5%
Attention Deficit/hyperactivity Disorder 1.5%
Tardive Dyskinesia 15.3%
Weight Increased 9.5%
Tremor 9.2%
Somnolence 8.6%
Dystonia 5.8%
Weight Decreased 5.4%
Vomiting 4.4%
Sedation 4.2%
Extrapyramidal Disorder 4.0%
Drug Ineffective 3.6%
Death 3.5%
Withdrawal Syndrome 3.5%
Insomnia 3.2%
Vision Blurred 3.2%
Swollen Tongue 3.0%
Malaise 3.0%
Electrocardiogram Qt Prolonged 2.8%
Suicidal Ideation 2.8%
Akathisia 2.8%
Neuroleptic Malignant Syndrome 2.6%
Secondary
Bipolar Disorder 21.5%
Depression 15.6%
Product Used For Unknown Indication 9.0%
Anxiety 8.3%
Schizophrenia 7.3%
Hypertension 4.5%
Psychotic Disorder 3.8%
Bipolar I Disorder 3.2%
Schizoaffective Disorder 3.1%
Drug Use For Unknown Indication 2.9%
Major Depression 2.7%
Sleep Disorder 2.4%
Affective Disorder 2.3%
Diabetes Mellitus 2.2%
Attention Deficit/hyperactivity Disorder 2.2%
Insomnia 2.1%
Paranoia 2.0%
Mood Swings 1.7%
Blood Cholesterol Increased 1.6%
Mania 1.5%
Weight Increased 17.5%
Tremor 9.5%
Tardive Dyskinesia 8.3%
Weight Decreased 6.8%
Somnolence 6.2%
Insomnia 4.2%
Drug Ineffective 4.1%
Suicidal Ideation 4.1%
Vomiting 3.8%
Withdrawal Syndrome 3.8%
Mental Disorder 3.6%
Dyskinesia 3.5%
Thinking Abnormal 3.5%
Swollen Tongue 3.2%
Dystonia 3.1%
Headache 3.1%
Feeling Abnormal 3.0%
Vision Blurred 3.0%
Dry Mouth 2.9%
Psychotic Disorder 2.9%
Concomitant
Depression 20.0%
Bipolar Disorder 19.0%
Schizophrenia 9.5%
Anxiety 8.6%
Product Used For Unknown Indication 5.8%
Sleep Disorder 5.7%
Insomnia 4.2%
Drug Use For Unknown Indication 3.6%
Pain 3.5%
Psychotic Disorder 2.6%
Smoking Cessation Therapy 2.5%
Hypertension 2.2%
Schizoaffective Disorder 2.1%
Affective Disorder 1.9%
Asthma 1.6%
Agitation 1.6%
Diabetes Mellitus 1.5%
Mental Disorder 1.4%
Gastrooesophageal Reflux Disease 1.4%
Bipolar I Disorder 1.3%
Type 2 Diabetes Mellitus 31.5%
Weight Increased 18.5%
Pancreatitis 7.6%
Diabetes Mellitus 4.9%
Tardive Dyskinesia 4.4%
Vomiting 4.2%
Type 1 Diabetes Mellitus 3.3%
Suicidal Ideation 2.9%
Vision Blurred 2.8%
Obesity 2.6%
Suicide Attempt 2.3%
Tremor 2.2%
Urinary Tract Infection 2.0%
Nausea 1.7%
Weight Decreased 1.6%
Rash 1.5%
Somnolence 1.5%
Diabetic Ketoacidosis 1.4%
Drug Ineffective 1.4%
Pulmonary Embolism 1.4%
Interacting
Product Used For Unknown Indication 12.4%
Depression 11.1%
Bipolar Disorder 9.8%
Schizophrenia 6.9%
Mental Disorder 5.8%
Anxiety 5.3%
Hallucination, Auditory 4.7%
Lennox-gastaut Syndrome 4.7%
Obsessive-compulsive Disorder 4.2%
Paranoia 4.2%
Ex-smoker 3.7%
Hallucination, Visual 3.7%
Psychotic Disorder 3.7%
Suicidal Ideation 3.7%
Sleep Disorder 3.2%
Affective Disorder 2.9%
Mania 2.6%
Mood Swings 2.6%
Dyspepsia 2.4%
Insomnia 2.4%
Suicidal Ideation 15.6%
Somnolence 11.1%
Drug Interaction 10.0%
Vomiting 6.7%
Withdrawal Syndrome 6.7%
Wrong Technique In Drug Usage Process 6.7%
Mania 5.6%
Serotonin Syndrome 5.6%
Drug Ineffective 4.4%
Tremor 4.4%
Speech Disorder 3.3%
Weight Increased 3.3%
Dystonia 2.2%
Feeling Abnormal 2.2%
Potentiating Drug Interaction 2.2%
Stress 2.2%
Suspiciousness 2.2%
Unevaluable Event 2.2%
White Blood Cell Count Decreased 2.2%
Agranulocytosis 1.1%